BioRestorative Therapies, Inc. Logo

BioRestorative Therapies, Inc.

Develops adult stem cell therapies for degenerative disc and metabolic disorders.

BRTX | US

Overview

Corporate Details

ISIN(s):
US0906556065
LEI:
Country:
United States of America
Address:
40 MARCUS DRIVE, 11747 MELVILLE

Description

BioRestorative Therapies, Inc. is a clinical-stage biotechnology company focused on developing regenerative medicine products and cell-based therapies. The company utilizes adult stem cells to address unmet medical needs, primarily in degenerative disc disease and metabolic disorders. Its lead clinical program, BRTX-100, is an autologous stem cell therapy for chronic lumbar disc disease currently in a Phase 2 clinical trial. Another development program, ThermoStem, uses brown adipose-derived stem cells to target metabolic conditions. In addition to its therapeutic pipeline, the company has a BioCosmeceutical platform that develops biologics based on secretome technology, including exosomes and growth factors, for aesthetic medicine applications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-19 16:06 English ZIP 8.1 KB
2025-12-12 23:11
PROSPECTUS RE 508,592 SHARES OF COMMON STOCK
English ZIP 58.2 KB
2025-12-11 06:15 English ZIP 5.2 KB
2025-11-18 22:48
S-8
English ZIP 60.9 KB
2025-11-18 22:45
S-1
English ZIP 167.3 KB
2025-11-12 23:00
10-Q
English ZIP 932.1 KB
2025-11-12 22:11
THIRD QUARTER 2025 FINANCIAL RESULTS
English ZIP 5.3 MB
2025-10-20 14:18 English ZIP 8.1 KB
2025-10-20 14:02 English ZIP 7.8 KB
2025-10-09 18:50 English ZIP 8.3 KB
2025-10-08 23:10
8-K
English ZIP 386.9 KB
2025-10-08 22:25
424B5
English ZIP 109.8 KB
2025-10-06 17:55
424B5
English ZIP 15.5 KB
2025-09-25 17:49
ANNUAL MEETING VOTE
English ZIP 61.9 KB
2025-08-14 23:08
PRESENTATION MATERIALS
English ZIP 15.3 MB

Automate Your Workflow. Get a real-time feed of all BioRestorative Therapies, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BioRestorative Therapies, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BioRestorative Therapies, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

HALOZYME THERAPEUTICS, INC. Logo
Biopharmaceutical firm licensing technology to convert IV drugs to subcutaneous forms.
United States of America
HALO
HEALIOS K.K. Logo
Clinical-stage biotech developing regenerative medicine and cell-based therapies.
Japan
4593
HeartSciences Inc. Logo
Medical technology company applying AI to electrocardiography for heart disease detection.
United States of America
HSCS
Heartseed株式会社 Logo
Clinical-stage biotech developing regenerative medicine for severe heart failure.
Japan
219A
Herantis Pharma Oyj Logo
A clinical-stage biotech developing therapies for neurodegenerative diseases like Parkinson's.
Finland
HRTIS
Hipower Energy Spolka Akcyjna Logo
Develops and commercializes hydrogen-based solutions and fuel cell technology.
Poland
HPE
HLB bioStep Co.,Ltd. Logo
A non-clinical CRO providing drug development services, specializing in veterinary medicine.
South Korea
278650
HLB PANAGENE Co., LTD. Logo
Specializes in PNA-based molecular diagnostics for oncology and infectious diseases.
South Korea
046210
HLB SCIENCE Inc. Logo
Develops drugs and diagnostics for infectious, immune, and Alzheimer's diseases.
South Korea
343090
Hoth Therapeutics, Inc. Logo
A clinical-stage biopharma company advancing drugs for unmet medical needs.
United States of America
HOTH

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.